Serial changes in scleroderma and idiopathic interstitial lung disease.
D000328:Adult; D000368:Aged; D001158:Arteries; D002248:Carbon Monoxide; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008170:Lung Compliance; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010396:Penicillamine / Q000008:administration & dosage / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011653:Pulmonary Diffusing Capacity; D011658:Pulmonary Fibrosis / Q000188:drug therapy / Q000503:physiopathology*; D012129:Respiratory Function Tests; D012595:Scleroderma, Systemic / Q000188:drug therapy / Q000503:physiopathology*; D013147:Spirometry; D013997:Time Factors; D014797:Vital Capacity
D002248:Carbon Monoxide; D003520:Cyclophosphamide; D015122:Mercaptopurine; D010396:Penicillamine; D010100:Oxygen; D011241:Prednisone